W. Bennett Love
Financieel Directeur/CFO bij BioKier, Inc.
Profiel
W.
Bennett Love was the founder of Synereca Pharmaceuticals, Inc. (founded in 2009) where he held the title of Secretary & Vice President-Business Operations.
He is currently the Director at NC Life Sciences Organization and the Chief Financial Officer & Vice President at BioKier, Inc. (since 2014).
In his former positions, he was the Director at Sphinx Pharmaceuticals Corp, Vice President at Incara Pharmaceuticals Corp., and Vice President-Business Operations at Ercole Biotech, Inc. Mr. Love obtained his undergraduate degree and MBA from The University of North Carolina at Charlotte.
Actieve functies van W. Bennett Love
| Bedrijven | Functie | Begin |
|---|---|---|
BioKier, Inc.
 BioKier, Inc. Pharmaceuticals: MajorHealth Technology BioKier, Inc. operates as a pharmaceutical company. It develops and markets drugs for diabetes and related disorders. The firm offers oral pills for the treatment of type 2 diabetes as well as for metabolic syndrome and obesity conditions. The company was founded by Roger D. Nolan and Jerzy R. Szewczyk in November 2008 and is headquartered in Chapel Hill, NC. | Financieel Directeur/CFO | - |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Directeur/Bestuurslid | - |
Eerdere bekende functies van W. Bennett Love
| Bedrijven | Functie | Einde |
|---|---|---|
Synereca Pharmaceuticals, Inc.
 Synereca Pharmaceuticals, Inc. Medical DistributorsDistribution Services Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. It focuses on compounds that enhance the activity of Colistin against gram-negative bacteria without enhancing its toxicity. The company was founded in 2009 by Clayton I. Duncan, Stephen B. Bocckino and Bennett W. Love and is headquartered in Oklahoma City, OK. | Oprichter | - |
| Incara Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| Sphinx Pharmaceuticals Corp | Directeur/Bestuurslid | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Corporate Officer/Principal | - |
Opleiding van W. Bennett Love
| The University of North Carolina at Charlotte | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
BioKier, Inc.
BioKier, Inc. Pharmaceuticals: MajorHealth Technology BioKier, Inc. operates as a pharmaceutical company. It develops and markets drugs for diabetes and related disorders. The firm offers oral pills for the treatment of type 2 diabetes as well as for metabolic syndrome and obesity conditions. The company was founded by Roger D. Nolan and Jerzy R. Szewczyk in November 2008 and is headquartered in Chapel Hill, NC. | Health Technology |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
| Incara Pharmaceuticals Corp. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
Synereca Pharmaceuticals, Inc.
Synereca Pharmaceuticals, Inc. Medical DistributorsDistribution Services Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. It focuses on compounds that enhance the activity of Colistin against gram-negative bacteria without enhancing its toxicity. The company was founded in 2009 by Clayton I. Duncan, Stephen B. Bocckino and Bennett W. Love and is headquartered in Oklahoma City, OK. | Distribution Services |
NC Life Sciences Organization
NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Commercial Services |
